# CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?

> **NCT07070934** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Xuzhou Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Multiple Myeloma
- Newly Diagnosed

## Interventions

- **BIOLOGICAL:** CAR-T
- **BIOLOGICAL:** ASCT

## Key facts

- **NCT ID:** NCT07070934
- **Lead sponsor:** Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-15
- **Primary completion:** 2026-07-15
- **Final completion:** 2028-07-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07070934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07070934, "CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07070934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*